Patients with encapsulated follicular variant papillary thyroid cancer frequently have the RAS mutations,19 and their disease is often indolent.20 In contrast, non-encapsulated follicular variants often harbor BRAF V600E mutations and can follow a more aggressive path.16,21. This evidence concerns the gene BRAF and thyroid gland papillary carcinoma.